Molecular Biology Enzymes and Kits & Reagents Market Report to 2022

Molecular biology enzymes and kits & reagents market is projected to reach USD 13.60 billion by 2022 from USD 6.52 billion in 2017, at a CAGR of 15.8% during the forecast period. The key factors driving the growth of this market include increased research activities and R&D investments inthe life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases & genetic disorders. However, limited reimbursements for genetic testing is expected to restrain the growth of this market during the forecast period.

Click Here for Complete Report on Molecular Biology Enzymes and Kits & Reagents Market spread across 170 Pages, Profiling 12 Companies and Supported with 88 Tables and 33 Figures at http://www.rnrmarketresearch.com/molecular-biology-enzymes-kits-reagents-market-by-application-cloning-epigenetics-pcr-restriction-digestion-sequencing-product-ligase-phosphatase-polymerase-protease-restriction-endonu-market-report.html .

Based on application, the market is segmented into polymerase chain reaction (PCR), sequencing, cloning, epigenetics, restriction digestion, synthetic biology, and other applications (mutagenesis, in vitro transcription, and molecular labeling & detection).The sequencing segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing DNA sequencing with growth in genomic research, rapid technological advancements, decreasing costs of sequencing, and growing use of whole-genome sequencing and personalized genome sequencing.

Introduction

1 Objectives of the Study

2 Market Definition

3 Markets Covered

4 Years Considered for the Study

5 Currency

6 Limitations

7 Stakeholders

Asia Pacific is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the APAC market is attributed to increasing government interest in the biomedical & biotechnology industries, the presence of bio-clusters in India and China, and growing outsourcing of clinical research activities to Asian countries.

Click Here for Sample Papers of Molecular Biology Enzymes and Kits & Reagents Market with Top Trends and Company Profile at http://www.rnrmarketresearch.com/contacts/request-sample?rname=201976 .

Molecular biology enzymes and kits & reagents market and aims at estimating market size and future growth potential of this market based on various segments such as product, application, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Competitive Landscape

1 Introduction

2 Market Share Analysis, 2016

The key players in the global molecular biology enzymes and kits & reagents market are Thermo Fisher(US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), and Molecular Biology Resources (US)

Click Now for More Details on “Molecular Biology Enzymes and Kits & Reagents Market by Product (Kits & Reagents, Enzymes), Application (PCR, Sequencing, Cloning, Epigenetics), End User (Academic & Research Institutes, Hospitals & Diagnostic Centers), and Region – Global Forecast to 2022” report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=201976 .

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies.

Contact:

[email protected]  / Call +1 888 391 5441

For further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.